JAKARTA (TheInsiderStories) – Indonesian foreign minister, Retno Marsudi, said the Indonesian government had secured 370 million doses vaccine powders until 2021 after holding talks with China and the United Arab Emirates. Its planned that this vaccine powder will be procured by three state-owned drug manufacturers, PT Biofarma, PT Kimia Farma Tbk (IDX: KAEF), and PT Indofarma Tbk (IDX: INAF).
“From the visits, we have secured 20 – 30 million vaccines (powder) for 2020 and 290 million – 340 million vaccines powder in 2021,” she told the media after a limited meeting with President Joko Widodo at the State Palace today (08/24)
During a visit to the United Arab Emirates (UEA) on Saturday, the chief executive of the committee to handle the COVID-19 and National Economic Recovery, Erick Thohir and Marsudi, has witnessed the signing of a memorandum of understanding between the state owned enterprises with companies in UAE.
The collaboration with G42, an artificial intelligence company based in Abu Dhabi, involves Kimia Farma and Indofarma. The memorandum of understanding emphasizes the application of laser-based Covid-19 detection tools in Indonesia, capacity agreements and development of vaccine, pharmaceutical production, and broad cooperation in the field of health services, including research and distribution.
According to Thohir in an official statement, Kimia Farma will focus on developing vaccine products, including the COVID-19 vaccine coverage of pharmaceutical products, health services, research and clinical trials, as well as marketing and distribution. Its planned that in the third quarter of 2021, G42 will deliver 10 million doses of the vaccine which is currently undergoing phase III clinical trials in Abu Dhabi, UAE.
In addition, Indofarma to emphasizes the procurement of test kits with laser technology to help tracing people who are exposed to the COVID-19 virus. He added that this cooperation will last for the long term. The parties, he continued, will conduct joint research, transfer technology, and develop the joint vaccine market for the Middle East and the African continent.
Previously, the two ministers had bilateral meetings with the State Councilor and the minister of foreign affairs of China, Wang Yi in Sanya, Hainan along with a number of Chinese pharmaceutical companies like Sinovac, CanSino Biologics and Sinopharm, regarding strengthening cooperation in the field of vaccines. Thohir explained that the distribution of vaccine raw materials from Sinovac will begin in November.
“We at the committee enlarge and make various efforts to reduce the spread of the virus while continuing to build national independence through the development of the Red and White vaccine and healing therapy, “he stated.
He emphasized that the Indonesian government also continues to be open and explore other international collaborations to ensure and accelerate the availability of a safe and effective COVID-19 vaccine in Indonesia.
Written by Editorial Staff, Email: email@example.com